Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancer Research|January 6, 2010
Characterization of melanoma cells capable of propagating tumors from a single cellMatthew A Held, David P Curley, David Dankort, et al.Cancer Research|December 6, 2006
Epigenetic silencing of novel tumor suppressors in malignant melanomaViswanathan Muthusamy, Sekhar Duraisamy, C Matthew Bradbury, et al.Blood|July 17, 2004
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518Jennifer J Clark, Jan Cools, David P Curley, et al.The American Journal of Emergency Medicine|July 17, 2014
Boarding is associated with higher rates of medication delays and adverse events but fewer laboratory-related delaysJiraporn Sri-On, Yuchiao Chang, David P Curley, et al.Genesis (New York, N.Y. : 2000)|May 6, 2006
Characterization of melanocyte-specific inducible Cre recombinase transgenic miceMarcus Bosenberg, Viswanathan Muthusamy, David P Curley, et al.Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse modelLouise M Kelly, Jeffrey L Kutok, Ifor R Williams, et al.Nature Genetics|March 14, 2009
Braf(V600E) cooperates with Pten loss to induce metastatic melanomaDavid Dankort, David P Curley, Robert A Cartlidge, et al.Cancer Cell|December 17, 2011
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomasWilliam E Damsky, David P Curley, Manjula Santhanakrishnan, et al.Blood|March 24, 2005
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotypeJoseph D Growney, Hirokazu Shigematsu, Zhe Li, et al.Oncogene|August 24, 2005
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse modelBenjamin H Lee, Ifor R Williams, Ema Anastasiadou, et al.Pageof 2